Track the BioPharmX Corp share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). The latest transaction was reported on 15 January 2016 (Acquisition). Among the most active insiders: Morlock Stephen. All data is free.
5
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
n/a
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
BioPharmX Corp is a company focused on developing pharmaceutical products for the treatment of skin diseases. It is listed on NASDAQ under the ticker XNAS.